Loss of Drop1 expression already at early tumor stages in a wide range of human carcinomas

International Journal of Cancer. Journal International Du Cancer
Alexander MarméHerwig Ponstingl

Abstract

In a study on gene deregulation in ovarian carcinoma we found a mRNA coding for a 350 kDa protein, Drop1, to be downregulated 20- to 180-fold in the majority of ovarian and mammary carcinomas. The mRNA is encoded by a set of exons in the 5' region of the SYNE1 gene. Immunohistochemical staining for Drop1 protein by a specific monoclonal antibody corresponds to the pattern seen for the mRNA. cDNA arrays of matched pairs of tumor and normal tissue and in situ hybridizations confirmed the drastic loss of Drop1 mRNA as a common feature in uterus, cervix, kidney, lung, thyroid and pancreas carcinomas, already at early tumor stages and in all metastases. Two-hybrid studies suggest a role of this deficiency in the malignant progression of epithelial tumors.

References

Nov 15, 1990·International Journal of Cancer. Journal International Du Cancer·G MechtersheimerP Möller
Mar 5, 1996·Proceedings of the National Academy of Sciences of the United States of America·E NediviD Hevron
Nov 8, 1996·Science·M R Emmert-BuckL A Liotta
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·J SchultzC P Ponting
Dec 1, 1996·Nature Biotechnology·J S WanM G Erlander
Aug 7, 2002·FEBS Letters·John M K MislowElizabeth M McNally
Jun 17, 2003·Molecular Biology of the Cell·Lisa Lucio GoughKenneth A Beck
Jul 2, 2003·Journal of Cancer Research and Clinical Oncology·Simone KayserBrigitte Gückel
Nov 26, 2003·Lancet Neurology·Francesco MuntoniAlessandra Ferlini
Dec 12, 2003·Nature Reviews. Cancer·Peng Liang, Arthur B Pardee
Jan 8, 2004·Journal of Cell Science·Jun Fan, Kenneth A Beck
Apr 20, 2004·Experimental Cell Research·V C PadmakumarElena Korenbaum
Jul 24, 2004·American Journal of Human Genetics·J E Bailey-WilsonM W Anderson
Aug 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paola ParrellaVito Michele Fazio
Dec 18, 2004·Molecular & Cellular Proteomics : MCP·Michael AlbersManfred Koegl
Feb 3, 2005·Nature Reviews. Molecular Cell Biology·Yosef GruenbaumKatherine L Wilson
Jul 19, 2005·Molecular and Cellular Biology·Mikko TaipaleAsifa Akhtar
Jan 18, 2006·EMBO Reports·Jeesun KimMark T Bedford
Jun 1, 2006·International Journal of Cancer. Journal International Du Cancer·G Bea A WismanAte G J van der Zee
Oct 31, 2006·Nature Genetics·Florian EckhardtStephan Beck
Dec 13, 2006·Journal of Cell Science·Kevin WilhelmsenArnoud Sonnenberg
Dec 13, 2006·Nature Genetics·François Gros-LouisGuy A Rouleau
Feb 27, 2007·Cell·Peter A Jones, Stephen B Baylin
May 16, 2007·Annals of Neurology·Nicolas DupréGuy A Rouleau

❮ Previous
Next ❯

Citations

Jul 9, 2013·Expert Reviews in Molecular Medicine·Dipen Rajgor, Catherine M Shanahan
Jan 9, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jennifer A DohertyUNKNOWN Ovarian Cancer Association Consortium (OCAC)
Jul 27, 2012·The Journal of Clinical Investigation·S Michael Rothenberg, Leif W Ellisen
May 28, 2014·The Journal of Cell Biology·Dipen RajgorCatherine M Shanahan
May 29, 2010·Annual Review of Cell and Developmental Biology·Daniel A Starr, Heidi N Fridolfsson
Apr 21, 2012·International Journal of Cell Biology·Surayya TaranumAngelika A Noegel
Jun 2, 2012·Cellular and Molecular Life Sciences : CMLS·Wenshu LuIakowos Karakesisoglou
Oct 6, 2010·The Journal of Cell Biology·Heidi N Fridolfsson, Daniel A Starr
Oct 1, 2011·The International Journal of Biochemistry & Cell Biology·Isabelle Dupin, Sandrine Etienne-Manneville
May 2, 2014·Nucleus·Ilknur SurAngelika A Noegel
Nov 27, 2010·Current Opinion in Cell Biology·Peter FriedlJan Lammerding
Jan 1, 2014·Seminars in Cell & Developmental Biology·Sarah Cartwright, Iakowos Karakesisoglou
Sep 17, 2019·Proteomics·Manuela Klingler-HoffmannPeter Hoffmann
Apr 22, 2017·Oncotarget·Mengyuan LiXiaosheng Wang
Nov 20, 2019·Molecular Biology Reports·Ilknur Sur-ErdemAngelika A Noegel
Sep 4, 2015·Endocrine-related Cancer·Tracy A O'MaraAmanda B Spurdle

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Jennifer A DohertyOvarian Cancer Association Consortium (OCAC)
Proceedings of the National Academy of Sciences of the United States of America
Kyle J RouxB Burke
© 2022 Meta ULC. All rights reserved